VivoSeq
Other

Retrograde Intrarenal Surgery

0

Pipeline Programs↗

2

Active Trials↗

0

Companies Involved↗

Retrograde Intrarenal Surgery is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

6

clinical trials

Completed2 · 33%
Unknown status2 · 33%
Enrolling by invitation1 · 17%
Not yet recruiting1 · 17%

Clinical Trials

Trial Activity

6 trials

Comparative Study of General Versus Spinal Anesthesia in Retrograde Intrarenal Surgery: Impact of Stone Size on Perioperative Outcomes
Not yet recruiting·SSouth Valley University·N/A·NCT07664384·80 enrolled
Retrograde Intrarenal Surgery Low Risk Trial
Enrolling by invitation·NNational Taiwan University Hospital·Phase 4·NCT06741917·200 enrolled
Silodosin in Retrograde Intrarenal Surgery
Completed·—·Phase 3·NCT05921370·60 enrolled
Evaluation of Sevoflurane Consumption During Initial Phase of Minimal-Flow Anesthesia in Retrograde Intrarenal Surgery
Completed·—·N/A·NCT07248917·62 enrolled
Comparison of Multiple-, Single- and Zero-dose of Ciprofloxacin Prophylaxis in Retrograde Intrarenal Surgery
Unknown status·—·N/A·NCT02304822·450 enrolled
Enhanced Versus Extended Preoperative Antibiotic Prophylaxis Regimens for Retrograde Intrarenal Surgery in High Infectious Risk Patients
Unknown status·MMansoura University·Phase 3·NCT05384197·280 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)